Fadi Alfayoumi is a Cardiology physician. OpenAlex indexes 5 publications with 430 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
844 Central Blvd Ste 380
Brownsville, TX 785207512
Telephone
956-698-5613Provider last certified this registry record 25 Sept 2024.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202511 payments
- ABIOMEDProgram year20254 payments
- PFIZER INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Beta blocker19.8%Carvedilol48%Metoprolol Succinate44%Metoprolol Tartrate4%Labetalol Hcl1%Atenolol1%Nebivolol Hcl1%Bisoprolol-Hydrochlorothiazide1%Part D<11 patientsStatin13.7%Atorvastatin Calcium78%Rosuvastatin Calcium17%Simvastatin2%Pravastatin Sodium2%Part D≥642 patients+ 19 more classes in this area
Blood & clotting
14.6%Factor Xa inhibitor7%Eliquis85%Xarelto15%Part D≥257 patientsP2Y12 inhibitor5.3%Clopidogrel86%Brilinta14%Part D≥224 patients+ 1 more class in this area
Metabolism & gastrointestinal
5%SGLT2 inhibitor3.9%Farxiga75%Jardiance23%Dapagliflozin2%Part D≥137 patientsPotassium supplement0.7%Potassium Chloride100%Part D≥34 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evolving clinical application of cardiac MRI.
PubMed
2007 - From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease
Progress in Cardiovascular Diseases
2006 - The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
PubMed
2005
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”